NCT03317522

Brief Summary

This study investigates the associations between measured maternal lipids (Total cholesterol, LDL-cholesterol , triglycerides and high-density lipoprotein cholesterol) at 28 weeks' gestation and offspring adiposity at 5-7 years. This was examined in a large observational study based in Belfast, UK.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,224

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2001

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 9, 2001

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 4, 2006

Completed
5.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2012

Completed
5.6 years until next milestone

First Submitted

Initial submission to the registry

October 10, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 23, 2017

Completed
Last Updated

October 23, 2017

Status Verified

October 1, 2017

Enrollment Period

5.8 years

First QC Date

October 10, 2017

Last Update Submit

October 20, 2017

Conditions

Keywords

Pregnancyteratogenesis

Outcome Measures

Primary Outcomes (2)

  • BMI Z score

    Adiposity expressed as body mass index (BMI) Z score

    5-7 years

  • Sum of skin fold thicknesses

    Sum of triceps, subscapular and suprailiac

    5-7 years

Study Arms (1)

Belfast HAPO

All pregnant women who attended the Royal Victoria Maternity Hospital, Belfast were eligible to participate unless they met one or more exclusion criteria. All eligible women from the Belfast centre were invited to take part in a prospective observational study involving an additional fasting serum sample for lipids at 28 weeks gestation and long term follow up of their HAPO offspring. Only those women who had remained blinded to oral glucose tolerance test (OGTT) results during pregnancy were included (fasting plasma glucose ≤5·8 mmol/L and 2-hour glucose ≤11·1 mmol/L). Offspring from these pregnancies had anthropometric measurements performed within 72 hours of birth and at age 5-7 years.

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsParticipants had to be pregnant to take part in study and therefore only female participants could be selected.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All pregnant women who attended the Royal Victoria Maternity Hospital were eligible to participate unless they met one or more of the exclusion criteria.

You may qualify if:

  • In a pregnant state in the first/second trimester
  • Attending the Royal Victoria Maternity Hospital

You may not qualify if:

  • Age younger than 18 years
  • A plan to undergo delivery at another hospital
  • An uncertain date of last menstrual period and no ultrasonographic estimation between 6 and 24 weeks of gestational age
  • Inability to complete the oral glucose-tolerance test within 32 weeks of gestation
  • Multiple pregnancy
  • Conception by means of gonadotropin ovulation induction or in vitro fertilization
  • Glucose testing before recruitment or a diagnosis of diabetes during the current pregnancy
  • Diagnosis of diabetes before the current pregnancy and requiring treatment with medication
  • Participation in another study that could interfere with the HAPO study
  • Infection with the human immunodeficiency virus or hepatitis B or C virus
  • Previous participation in the HAPO study
  • Inability to converse in the languages used on centre forms without the aid of an interpreter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum samples remain for a number of participants.

MeSH Terms

Conditions

ObesityTeratogenesis

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • David R McCance, MD

    Belfast Health and Social Care Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2017

First Posted

October 23, 2017

Study Start

January 9, 2001

Primary Completion

November 4, 2006

Study Completion

March 14, 2012

Last Updated

October 23, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share